284 related articles for article (PubMed ID: 33960690)
21. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
22. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
23. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
24. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
Yang Z; Liu L; Leng K; Shi G
J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
[TBL] [Abstract][Full Text] [Related]
25. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS
J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
28. Second primary malignancies after ocular adnexal lymphoma diagnosis.
Loya A; Ramachandran V; Ayaz T; Weng CY
BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
[TBL] [Abstract][Full Text] [Related]
29. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
[TBL] [Abstract][Full Text] [Related]
30. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I
J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382
[TBL] [Abstract][Full Text] [Related]
31. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
32. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
33. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis.
Banner L; Rohan TZ; Zachian R; Gross T; Yang HY; Joffe D; Porcu P; Nikbakht N
J Am Acad Dermatol; 2024 Jul; 91(1):151-153. PubMed ID: 38513830
[No Abstract] [Full Text] [Related]
34. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
Jiang S; Zhen H; Jiang H
Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
[TBL] [Abstract][Full Text] [Related]
35. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
36. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
37. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
38. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
39. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
40. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]